Promising immunomodulators for management of substance and alcohol use disorders

  • Published on 06/11/2024
  •  Reading time: 4 min.

Amanda M. Acuña a , Connor Park b , Jonna M. Leyrer-Jackson b & M. Foster Olive a,*

a Department of Psychology, Behavioral Neuroscience and Comparative Psychology Area, Arizona State University, Tempe, Arizona, USA
b Department of Medical Education, Creighton University School of Medicine - Phoenix Campus, Phoenix, Arizona, USA

CONTACT M. Foster Olive mailto:foster.olive@asu.edu Department of Psychology, Behavioral Neuroscience and Comparative Psychology Area, Arizona State University, 950 S. McAllister Ave, Tempe, AZ 85287, USA

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Psychiatry

Receive our newsletter to stay up to date with the latest news in Psychiatry

More articles

From peer-reviewed journals in Psychiatry